U.S. IT Stock News

In recent days, AppLovin held its June 3 annual meeting where shareholders approved adding Delaware-permitted officer exculpation to its charter and rejected a proposal to disclose voting results by share class, while the company also scheduled a June 9 investor conference appearance in London following strong first-quarter results powered by its AXON AI ad engine and e-commerce expansion. These governance moves and investor outreach come as AppLovin shifts further toward a pure-play ad tech...

Recent share performance and business scale PepsiCo (PEP) has drawn attention after a period where the stock is down about 8% over the past month and roughly 11% over the past 3 months, despite a market value near US$192.3b. The company reports annual revenue of about US$95.4b and net income of roughly US$8.7b, with recent annual revenue growth of 3.5% and net income growth of 8.5%. Its last close was US$142.78, and PepsiCo carries a value score of 4, which some investors may use as a quick...

Recent performance snapshot POET Technologies (POET) has drawn attention after a sharp 12.3% single day decline, extending a 22.1% slide over the past week. This contrasts with relatively flat performance over the past month. See our latest analysis for POET Technologies. Despite the recent slide, POET Technologies still has strong longer term momentum. The 90 day share price return of 44.8% and 1 year total shareholder return of 152.8% stand out for investors tracking volatility and...

International Paper is partnering with Canadian Pacific Kansas City on a new 468,000-square-foot packaging facility in Mississippi. The site is planned with direct rail access to support inbound materials and outbound shipments across North America. The facility is expected to be operational in Q4 2027 as part of International Paper's broader transformation in packaging and logistics. For investors watching NYSE:IP, this project comes amid a mixed share performance backdrop. The stock...

In late May 2026, Penguin Solutions, Inc. announced that Chief Financial Officer and Senior Vice President Nate Olmstead will resign effective July 8, 2026, with Vice President of Finance and Accounting Aaron Johnson stepping in as interim CFO and principal financial and accounting officer from July 9, 2026. At the same time, Penguin reaffirmed its fiscal 2026 guidance and now expects net sales and diluted EPS to land at the top of prior ranges, citing very strong agentic AI-driven demand...

In early June 2026, The Southern Company filed an omnibus shelf registration covering common and preferred stock, multiple note classes, and stock purchase securities, and subsequently launched a US$50.0 million at-the-market common equity offering. This fresh equity-raising capacity comes as Southern reports stronger earnings tied to surging data center power demand and extends its multi-decade dividend growth record. Now we’ll examine how this combination of increased data center-driven...

Pegasystems recently used its PegaWorld conference to unveil Pega Infinity 26, a suite of AI-powered upgrades spanning development, customer engagement, pricing, and mainframe modernization, including the new Pega Infinity Studio and Customer Engagement Studio. The company is positioning its “Predictable AI” architecture and expanded AWS integration as a way for enterprises to scale agentic AI with stronger governance and more controllable costs, while also investing in free training to...

UGI (UGI) is in the middle of a broad reshaping of its business, from selling its electric division and building out natural gas infrastructure to expanding online propane sales and delivering on early ESG commitments. See our latest analysis for UGI. Recent moves like the electric division sale, new gas infrastructure projects in Pennsylvania and online AmeriGas propane sales have come alongside a 1 month share price return of about 7%, while the year to date share price is still down around...

Braze (BRZE) stock came into focus after first quarter results showed sales of US$211 million, a smaller net loss, and guidance for higher revenue, even though the shares fell following the report. See our latest analysis for Braze. At a share price of US$23.07, Braze has seen a 23.43% 90 day share price return but is down 29.12% year to date, with a 1 year total shareholder return that declined 24.73%. This suggests recent momentum has firmed up following a weaker stretch. If you are looking...

Bread Financial Holdings (BFH) has drawn investor attention after recent share price gains coincided with fresh performance metrics, including revenue of US$2.64b and net income of US$558 million for its tech-focused lending and payment services. See our latest analysis for Bread Financial Holdings. At a latest share price of US$91.42, Bread Financial Holdings has seen a 90 day share price return of 25.94% and a 1 year total shareholder return of 80.81%, which indicates that momentum has been...

Why Steven Madden (SHOO) Is Back on Investors’ Radar Steven Madden (SHOO) moved into focus after fiscal first quarter 2026 results came in ahead of estimates, with management lifting full year revenue guidance and outlining expectations for earnings growth and margin improvement. For you as an investor, that combination of outperformance against expectations, higher guidance and a clearer earnings path can be an important signal about how management views current business trends and demand...

In the past, several law firms, including Levi & Korsinsky, Rosen Law Firm and Holzer & Holzer, announced securities class action lawsuits against Regencell Bioscience Holdings after the company disclosed a Department of Justice subpoena into trading of its ordinary shares. The cases focus on allegations that Regencell issued materially false or misleading statements and failed to disclose its vulnerability to market manipulation during the October 28, 2024 to October 31, 2025 period...

Recent commentary around Sensata Technologies Holding (ST) has centered on its shift away from traditional auto supply toward higher margin industrial and aerospace markets, a change led by its new CEO and reinforced by portfolio streamlining. See our latest analysis for Sensata Technologies Holding. Recent portfolio changes and the shift toward industrial and aerospace markets appear to be feeding into sentiment, with the share price at US$50.17 and a 90 day share price return of 49.58%,...

Jacobs Solutions: recent returns and business mix Jacobs Solutions (J) has drawn investor attention after a period of mixed share performance, with short term returns soft yet longer multiyear figures remaining positive. This has prompted closer focus on how its global consulting and infrastructure operations stack up. See our latest analysis for Jacobs Solutions. At a share price of US$119.96, Jacobs Solutions has seen its short term momentum soften, with the share price return declining...

Why Avnet Stock Is On Investors’ Radar Avnet (AVT) has drawn fresh attention after recent gains, with the stock closing at US$87.05 and posting solid total returns over the past year, the past 3 months, and the past month. See our latest analysis for Avnet. The recent move to US$87.05 comes after a strong run, with a 30 day share price return of 6.04% and a 1 year total shareholder return of 72.78%. This points to momentum that investors are still watching closely. If Avnet’s run has you...

Joby Aviation has already begun flying its electric air taxis over major cities and, through a White House-backed program, secured opportunities to operate in 11 US states as part of broader efforts to expand sustainable, low-emission air transport. These developments position Joby at the center of the emerging electric aircraft market, where vertical takeoff and landing platforms are expected to play a leading role in future urban and regional mobility networks. Next, we’ll examine how...

Recent performance snapshot for Allstate (ALL) Allstate (ALL) has seen mixed share performance, with the stock down about 2.7% over the past day but up roughly 3.8% over the past week and 5.5% year to date. Over the past month, the stock is up about 0.9%, and over the past 3 months it has gained roughly 3.6%. This provides investors with a reference point for how recent moves compare with longer holding periods. For context, Allstate reports annual revenue of about US$68.2b and net income of...

Recent performance snapshot for StoneCo (NasdaqGS:STNE) StoneCo (NasdaqGS:STNE) has drawn fresh attention after a period of mixed share performance, with the stock up 1.6% over the past day but down over the past week, month, past 3 months, and year to date. In this context, investors are weighing StoneCo’s current share price of $10.57, its recent annual revenue of R$13,535.522 and net income of R$3,625.311, along with a mid-range value score of 5 and an intrinsic discount estimate of...

Recent share performance context Novo Nordisk (NYSE:NVO) has been on many investors’ radar after a period of mixed share performance, with the stock down over the past month but higher over the past 3 months. At a last close of US$41.02, the stock is also lower over the year to date and the past year, while the 5 year total return remains positive. This gives investors a wide range of recent return experiences to consider. See our latest analysis for Novo Nordisk. Short term momentum has...

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...

Celldex Therapeutics overview and recent stock context Celldex Therapeutics (CLDX) has drawn investor attention after recent trading, with the stock closing at US$28.56. Short term moves included a 0.2% decline over the past day and a 5.2% pullback over the past week. See our latest analysis for Celldex Therapeutics. The recent pullback, including a 16% decline in the 1 month share price return, sits against a stronger backdrop, with a 1 year total shareholder return of 37.9% but weaker 3 and...

Disc Medicine recently reported updated Phase 2 RALLY-MF data showing that its investigational drug DISC-0974 produced meaningful improvements in anemia outcomes for myelofibrosis patients, while also launching a U.S. expanded access program for bitopertin in erythropoietic and X-linked protoporphyria. At the same time, the company is facing an FDA Complete Response Letter on bitopertin and a related shareholder investigation alleging potentially misleading disclosures, raising questions...

On June 1, 2026, a shareholder of New York Times (NYT), the National Center for Public Policy Research, formally demanded access to internal records after a Nicholas Kristof column sparked criticism and legal threats. See our latest analysis for New York Times. The recent activist pressure arrives after a softer near term patch for the stock, with the share price down 6.8% over the past 30 days and 6.1% over 90 days, yet backed by a 34.6% 1 year total shareholder return and a 106.3% 3 year...

PDD Holdings Inc. reported past first-quarter 2026 results with sales of CNY 106,229 million, net income of CNY 12,547 million, and lower basic and diluted earnings per share from continuing operations versus a year earlier. The earnings release highlighted management’s continued heavy investment in supply chain upgrades and Temu’s global expansion, even as profitability softened year over year. Now, we’ll examine how weaker earnings alongside ongoing supply chain and Temu investments affect...